22354-83-2 Usage
Description
4-Benzyl-3-bromo-2-1,2,4-triazolin-5-one is a heterocyclic chemical compound with the molecular formula C9H8BrN3O. It features a triazolinone ring with a benzyl and bromine substituent, which contributes to its potential pharmacological properties.
Uses
Used in Pharmaceutical Development:
4-Benzyl-3-bromo-2-1,2,4-triazolin-5-one is used as a reactant in the synthesis of various organic compounds, particularly for the development of new pharmaceuticals. Its diverse biological activities make it a promising candidate for creating innovative drugs.
Used in Agrochemical Development:
In the agrochemical industry, 4-Benzyl-3-bromo-2-1,2,4-triazolin-5-one is utilized for its potential applications in developing new agrochemicals, capitalizing on its biological properties to enhance crop protection and management.
Used in Antitumor Research:
4-Benzyl-3-bromo-2-1,2,4-triazolin-5-one is used as an antitumor agent in pharmacological studies. Its potential to combat cancer is being investigated, which could lead to the development of new cancer treatments.
Used in Anti-inflammatory Applications:
4-Benzyl-3-bromo-2-1,2,4-triazolin-5-one is also used for its anti-inflammatory activity, being studied for its capacity to reduce inflammation, which may have implications for treating various inflammatory conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 22354-83-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,3,5 and 4 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 22354-83:
(7*2)+(6*2)+(5*3)+(4*5)+(3*4)+(2*8)+(1*3)=92
92 % 10 = 2
So 22354-83-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrN3O/c10-8-11-12-9(14)13(8)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,12,14)
22354-83-2Relevant articles and documents
1,2,4-TRIAZOLINOE CB1 INHIBITORS
-
Page/Page column 109; 110, (2021/09/11)
Disclosed are compounds according to Formula (I), and related pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating diseases such as diabetic kidney disease, diabetic nephropathy, obesity-related kidney disease, focal segmental glomerular sclerosis, IgA nephropathy, nephrotic syndrome, kidney fibrosis, Prader Willi syndrome, metabolic syndrome, gastrointestinal diseases, non-alcoholic liver disease, alcoholic liver disease, or non-alcoholic fatty liver disease, using the compounds of Formula (I).
